Eli Lilly to offer Zepbound single-dose vials for $499 per month

Eli Lilly (LLY) announced that the highest approved doses of Zepbound-12.5 mg and 15 mg-will soon be available in single-dose vials for $499 per month through LillyDirect’s Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey Program. Health care providers can begin prescribing the 12.5 mg and 15 mg vials on July 7, and shipments to patients will begin in early August. With the addition of these doses, every strength of Zepbound vial will be available for $499/month or less to any eligible adult with obesity and a valid prescription, regardless of insurance.